Compare MAIN & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MAIN | NOVT |
|---|---|---|
| Founded | 2007 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.0B |
| IPO Year | 2014 | 1999 |
| Metric | MAIN | NOVT |
|---|---|---|
| Price | $58.28 | $146.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $61.57 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 580.1K | 405.9K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 8.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.93 | 0.82 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | $6.27 | $8.61 |
| Revenue Next Year | $5.14 | $6.57 |
| P/E Ratio | ★ $62.55 | $177.98 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $48.95 | $98.27 |
| 52 Week High | $67.26 | $176.38 |
| Indicator | MAIN | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 62.02 | 39.53 |
| Support Level | $54.60 | $132.80 |
| Resistance Level | $59.55 | $144.38 |
| Average True Range (ATR) | 1.17 | 7.07 |
| MACD | -0.05 | -1.38 |
| Stochastic Oscillator | 74.99 | 1.60 |
Main Street Capital Corp is a principal investment firm focused on providing customized long-term debt and equity capital solutions to lower middle market ("LMM") companies and debt capital to private ("Private Loan") companies owned by or in the process of being acquired by a private equity fund. The group invests principally in secured debt investments, equity investments, warrants, and other securities of LMM companies, typically based in the U.S. The company operates as a single segment with a principal investment objective to maximize total return by generating current income from debt investments and current income and capital appreciation from equity and equity-related investments.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.